Clinical Diagnostics Laboratory Articles & Analysis
12 news found
Today, the Baker-Polito Administration announced that more than $1.5 million has been awarded to four projects that seek to increase testing capacity and provide solutions for coronavirus testing. The funding is through the Accelerating Coronavirus Testing Solutions (A.C.T.S.) Program, designed and administered by the Massachusetts Life Sciences Center, which supports projects focused on two core ...
SYNLAB LABORATORIES TO PERFORM ONCODEEP® BIOMARKER TEST TO HELP DOCTORS DECIDE ON THE MOST EFFECTIVE TREATMENT FOR THEIR CANCER PATIENTS ONCODNA, A GENOMIC AND THERANOSTIC COMPANY SPECIALIZING IN PRECISION MEDICINE FOR THE TREATMENT OF CANCER AND GENETIC DISEASES, ANNOUNCED TODAY A PARTNERSHIP WITH SYNLAB, EUROPE’S LEADING CLINICAL ...
As assay developers and clinical testing laboratories consider next steps for molecular diagnostics post-pandemic, a new in vitro diagnostic (IVD) system from Thermo Fisher Scientific will enable them to expand their assay menus and IVD testing capabilities moving forward. ...
This is an important addition to our service and product portfolio,” explains Damla Bozkulak, Head of Marketing and Business Development at Gen Era Diagnostics. Gen Era Diagnostics is one of the leading product and service providers in the field of molecular diagnostics in Turkey. ...
TeraRecon's multi-specialty advanced visualization solution, Intuition Titanium, will be fully integrated with Pixeon's PACS, known as Pixeon Aurora. With full clinical functionality for radiologists, cardiologists, vascular surgeons, and other specialty clinicians, the end-to-end solution will deliver premium imaging analysis tools and optimized workflows to Pixeon customers, ...
From March 28 to March 30, 2021, the 18th China International Laboratory Medicine and Blood Transfusion Instruments and Reagent Expo was successfully held at Chongqing International Expo Center. ...
The innovative product enables clinical laboratories and assay developers to meet testing demands and enhance their molecular diagnostics workflows. Clinical diagnostic and hospital laboratories across the United States have ramped up PCR testing over the last year in response to the global ...
We are happy to announce that RAMCON will be adding the clinical diagnostics solutions from Beckman Coulter to our product portfolio, starting January 1 2021! RAMCON has been a long time Beckman Coulter partner, and we are pleased to consolidate our business relationship even further. We are looking forward to bring our high level of knowledge and experience in to play and strengthen the market ...
ByRAMCON
(NYSE: TMO), the world leader in serving science, announced it will expand its response to the COVID-19 pandemic by developing a total antibodies test in collaboration with WuXi Diagnostics and Mayo Clinic. The new test is the result of ongoing collaboration between all three organizations, including clinical evaluation and support from Mayo ...
Thermo Fisher Scientific has expanded its portfolio of analytical instruments for clinical diagnostic laboratories with the addition of three systems now listed as Class I medical devices with the United States Food and Drug Administration (U.S. FDA). The portfolio enables clinical diagnostic ...
Shara Rudner, RPh., FIACP, FACA, Director, Clinical Trials Group for Restore Health, partnered with the research team at Allovate that developed the new toothpaste delivery system. ...
Shara Rudner, RPh., FIACP, FACA, Director, Clinical Trials Group for Restore Health, partnered with the research team that developed the new toothpaste delivery system. ...